EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space ( DTI ‐ ALPS) , is Linked to Poor Cognitive Outcomes in Parkinson's Disease

Angeliki Zarkali iD, George Thomas iD, Ross Paterson, Naomi Hannaway, Ivelina Dobreva iD, Amanda J Heslegrave, Elena Veleva, Henrik Zetterberg, Rimona S Weil iD

Movement Disorders · 2025

DOI: 10.1002/mds.30325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Angeliki Zarkali und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dementia Research Centre, Institute of Neurology, University College London, London, UK. Hauptthemen laut MEDLINE: Parkinson Disease, Diffusion Tensor Imaging, Cognitive Dysfunction, Glymphatic System. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Alzheimer's Research UK, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Impaired glymphatic clearance may contribute to pathological accumulations in Parkinson's (PD), but how it interacts with other processes causing dementia remains unclear. Diffusion tensor image analysis along the perivascular space (DTI‐ALPS) has been proposed as an indirect proxy for glymphatic clearance.

Objectives

To clarify DTI‐ALPS' relationship with cognition in PD, and its relationship with established imaging markers.

Methods

We assessed DTI‐ALPS in 98 PD patients (31 PD poor outcomes: dementia, mild cognitive impairment, frailty, or death within a 3‐year follow‐up; 67 PD good outcomes) and 28 controls. We assessed DTI‐ALPS' relationship to cognition, white matter (fiber cross‐section), cortical thickness, iron accumulation (quantitative susceptibility mapping [QSM]), and plasma markers [phosphorylated tau‐181 ( p ‐tau181 and neurofilament light (NfL)] cross‐sectionally and longitudinally).

Results

DTI‐ALPS was lower in PD‐poor outcomes compared with PD good outcomes and controls ( P = 0.005) with further longitudinal reductions only in PD poor outcomes (group × time interaction: β = −0.013, P = 0.021). Lower DTI‐ALPS was associated with lower fiber cross‐section in PD, at baseline and longitudinally but with different spatial distribution from white matter changes relating to PD cognition. There was no correlation between baseline DTI‐ALPS and plasma p ‐tau181 ( P = 0.642), NFL ( P = 0.448), or baseline cortical thickness. Lower DTI‐ALPS was associated with accelerated cortical thinning within left precentral gyrus and changes in brain iron distribution.

Conclusions

PD patients who develop poor outcomes show lower DTI‐ALPS, potentially reflecting impaired glymphatic clearance. DTI‐ALPS correlated with white matter integrity and brain iron accumulation. However, both showed different spatial distribution than that seen in PD dementia, suggesting DTI‐ALPS captures a distinct contribution to cognitive decline. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDiffusion Tensor ImagingCognitive DysfunctionGlymphatic SystemHumansMaleFemaleAgedMiddle AgedWhite MatterCross-Sectional Studiestau ProteinsDementiaNeurofilament Proteins

Stichwörter der Autor:innen

Parkinson's dementiaParkinson's diseasecortical thicknessglymphatic clearanceiron accumulationwhite matter degeneration

Substanzen

tau ProteinsNeurofilament Proteins

Autor:innen und Institutionen

  • Dementia Research Centre, Institute of Neurology, University College London, London, UK.
  • National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
  • UK DRI Fluid Biomarker Lab and Biomarker Factory, University College London, London, UK.
  • Movement Disorders Centre, Institute of Neurology, University College London, London, UK.
  • Department of Imaging Neuroscience, Institute of Neurology, University College London, London, UK.

ORCID-Profile: Angeliki Zarkali, George Thomas, Ivelina Dobreva, Rimona S Weil

Förderung

  • Wellcome Trust
  • Alzheimer's Research UK
  • National Institute for Health and Care Research

Zitieren

APA

Zarkali, A., Thomas, G., Paterson, R., Hannaway, N., Dobreva, I., Heslegrave, A. J., Veleva, E., Zetterberg, H., & Weil, R. S. (2025). Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space ( DTI ‐ ALPS) , is Linked to Poor Cognitive Outcomes in Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.30325

Vancouver

Zarkali A, Thomas G, Paterson R, Hannaway N, Dobreva I, Heslegrave AJ, et al. Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space ( DTI ‐ ALPS) , is Linked to Poor Cognitive Outcomes in Parkinson's Disease. Movement Disorders. 2025. doi:10.1002/mds.30325

BibTeX
@article{Zarkali2025,
  author = {Zarkali, Angeliki and Thomas, George and Paterson, Ross and Hannaway, Naomi and Dobreva, Ivelina and Heslegrave, Amanda J and Veleva, Elena and Zetterberg, Henrik and Weil, Rimona S},
  title = {Impaired Glymphatic Clearance, Measured Using Diffusion Tensor Image Analysis Along the Perivascular Space ( DTI ‐ ALPS) , is Linked to Poor Cognitive Outcomes in Parkinson's Disease},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.30325}
}
Kostenlos starten →